John F. Oram

John F. Oram publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where John F. Oram sits on this spectrum.

John F. Oram D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where John F. Oram sits on this spectrum.

Overview

Best Publications

• Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL

  Tomas Vaisar;Subramaniam Pennathur;Pattie S. Green;Sina A. Gharib

  1100
  Citations

• The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway

  Richard M. Lawn;David P. Wade;Michael R. Garvin;Xingbo Wang

  909
  Citations

• ATP-Binding Cassette Transporter A1: A Cell Cholesterol Exporter That Protects Against Cardiovascular Disease

  John F. Oram;Jay W. Heinecke

  693
  Citations

• ABCA1 Is the cAMP-inducible Apolipoprotein Receptor That Mediates Cholesterol Secretion from Macrophages

  John F. Oram;Richard M. Lawn;Michael R. Garvin;David P. Wade

  667
  Citations

• ABCA1. The gatekeeper for eliminating excess tissue cholesterol.

  John F. Oram;Richard M. Lawn

  621
  Citations

• Defective removal of cellular cholesterol and phospholipids by apolipoprotein A-I in Tangier Disease.

  Gordon A. Francis;Robert H. Knopp;John F. Oram

  602
  Citations

• The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport

  Constanze Bergt;Subramaniam Pennathur;Xiaoyun Fu;Jaeman Byun

  559
  Citations

• ATP-Binding Cassette Cholesterol Transporters and Cardiovascular Disease

  John F. Oram;Andrew T. M. Vaughan

  529
  Citations

• Apolipoprotein-mediated removal of cellular cholesterol and phospholipids

  John F. Oram;Shinji Yokoyama

  519
  Citations

• Regulation of high density lipoprotein receptor activity in cultured human skin fibroblasts and human arterial smooth muscle cells.

  John F. Oram;Eliot A. Brinton;Edwin L. Bierman

  385
  Citations

• ABCA1-mediated transport of cellular cholesterol and phospholipids to HDL apolipoproteins.

  John F. Oram;Ashley M. Vaughan

  348
  Citations

• HDL Apolipoproteins and ABCA1 Partners in the Removal of Excess Cellular Cholesterol

  John F. Oram

  346
  Citations

• Thematic review series: The immune system and atherogenesis. Lipoprotein-associated inflammatory proteins: markers or mediators of cardiovascular disease?

  Alan Chait;Chang Yeop Han;John F. Oram;Jay W. Heinecke

  339
  Citations

• ABCG1 Redistributes Cell Cholesterol to Domains Removable by High Density Lipoprotein but Not by Lipid-depleted Apolipoproteins

  Ashley M. Vaughan;John F. Oram

  337
  Citations

• Tyrosine 192 in apolipoprotein A-I is the major site of nitration and chlorination by myeloperoxidase, but only chlorination markedly impairs ABCA1-dependent cholesterol transport.

  Baohai Shao;Constanze Bergt;Xiaoyun Fu;Pattie Green

  336
  Citations

• ABCA1 and ABCG1 or ABCG4 act sequentially to remove cellular cholesterol and generate cholesterol-rich HDL

  Ashley M. Vaughan;John F. Oram

  331
  Citations

• The Macrophage Cholesterol Exporter ABCA1 Functions as an Anti-inflammatory Receptor

  Chongren Tang;Yuhua Liu;Peter S. Kessler;Ashley M. Vaughan

  323
  Citations

• Unsaturated Fatty Acids Inhibit Cholesterol Efflux from Macrophages by Increasing Degradation of ATP-binding Cassette Transporter A1

  Yutong Wang;John F. Oram

  319
  Citations

• Tangier disease and ABCA1

  John F. Oram

  319
  Citations

• Protein kinase C as a mediator of high density lipoprotein receptor-dependent efflux of intracellular cholesterol.

  A J Mendez;J F Oram;E L Bierman

  318
  Citations